Duration of Adjuvant Chemotherapy for Stage III Colon Cancer-Reference-Cited by-同舟云学术

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Published:2018-03-29 Issue:13 Volume:378 Page:1177-1188
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Grothey Axel¹,Sobrero Alberto F.¹,Shields Anthony F.¹,Yoshino Takayuki¹,Paul James¹,Taieb Julien¹,Souglakos John¹,Shi Qian¹,Kerr Rachel¹,Labianca Roberto¹,Meyerhardt Jeffrey A.¹,Vernerey Dewi¹,Yamanaka Takeharu¹,Boukovinas Ioannis¹,Meyers Jeffrey P.¹,Renfro Lindsay A.¹,Niedzwiecki Donna¹,Watanabe Toshiaki¹,Torri Valter¹,Saunders Mark¹,Sargent Daniel J.¹,Andre Thierry¹,Iveson Timothy¹

Affiliation:

1. From the Divisions of Medical Oncology (A.G.) and Biomedical Statistics and Informatics (Q.S., J.P.M., L.A.R., D.J.S.), Mayo Clinic, Rochester, MN; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST, Genoa (A.F. Sobrero), Ospedale Papa Giovanni XXIII, Bergamo (R.L.), and IRCCS Mario Negri Institute for Pharmacological Research, Milan (V.T.) — all in Italy; Karmanos Cancer Institute, Wayne State University, Detroit (A.F. Shields); National Cancer Center Hospital East, Chiba (T....

Funder

Japanese Foundation for Multidisciplinary Cancer Treatment

Agenzia Italiana del Farmaco

Efficacy and Mechanism Evaluation Programme

Cancer Research United Kingdom

National Institute for Health Research, Health Technology Assessment

Institut National du Cancer

Programme Hospitalier de Recherche Clinique en Cancérologie

NIH Clinical Center

Publisher

Massachusetts Medical Society

Subject